Diggs, A., Dioun, S., Chen, L., St. Clair, C., de Meritens, A. B., Hou, J., Khoury-Collado, F., & Wright, J. (2023). Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy (2204). Gynecologic Oncology, 176, S259. https://doi.org/10.1016/j.ygyno.2023.06.324
Publication Date
Columbia Affiliation
View